FDA to create and staff inspection offices in China, India

The FDA plans to create and staff inspection offices throughout China and India, and possibly other countries, as a means to step up its regulatory enforcement of the growing inventory of drug products being made abroad, commissioner Andrew von Eschenbach told a House Energy and Commerce subcommittee hearing.
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory